Bilateral pallidal deep-brain neurostimulation (DBS) has been shown to improve motor symptoms and overall quality of life in patients with severe primary generalized dystonia, but the long-term ...
June 25, 2008 (Chicago, Illinois) — Twenty-six patients with genetically confirmed DYT1 dystonia had improvement in their motor signs with pallidal deep-brain stimulation (DBS) for at least 3 years ...
Two patients freed from severe to disabling effects of dystonia through deep brain stimulation therapy continued to have symptom relief for months after their devices accidentally were fully or partly ...
Recent discoveries made by researchers from Charité – Universitätsmedizin Berlin may prove vital in improving the treatment of dystonia, a neurological movement disorder. Published in PNAS, their ...
February 12, 2008 — Researchers have described a novel, autosomal recessive young-onset dystonia parkinsonism syndrome in 2 Brazilian families, as well as the genetic mutation that appears to underlie ...
Geneva, Switzerland, 4 September 2013 - Addex Therapeutics (ADXN.SW), a leading company pioneering allosteric modulation-based drug discovery and development announced today additional positive ...
Addex Therapeutics / Addex Dipraglurant Normalizes Striatal Cholinergic Dysfunction in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 (DYT1). Processed and transmitted by ...
Dystonia is a neurologic movement disorder characterized by involuntary, sustained, patterned, repetitive muscle contractions, usually of opposing muscles. These contractions, which typically affect ...
Two patients freed from severe to disabling effects of dystonia through deep brain stimulation therapy continued to have symptom relief for months after their devices accidentally were fully or partly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results